DRRX - DURECT CORP
0.582
-0.007 -1.203%
Share volume: 41,243
Last Updated: 05-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.13%
PREVIOUS CLOSE
CHG
CHG%
$0.59
-0.01
-0.01%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | |
| Report Date | 05-09-2023 | 08-10-2023 | 11-14-2023 | 03-28-2024 | 05-14-2024 | 08-14-2024 | 11-14-2024 | 03-27-2025 | |
| Total revenue | 2.054 M | 2.081 M | 1.744 M | 2.669 M | 1.827 M | 2.171 M | 1.927 M | -3.894 M | |
| Cost of revenue | 388.000 K | 359.000 K | 312.000 K | 658.000 K | 289.000 K | 356.000 K | 513.000 K | -1.080 M | |
| Gross profit | 1.666 M | 1.722 M | 1.432 M | 2.011 M | 1.538 M | 1.815 M | 1.414 M | -2.814 M | |
| 3.36% | -16.84% | 40.43% | -23.52% | 18.01% | -22.09% | -299.01% | |||
| Operating expenses | 12.688 M | 11.773 M | 10.989 M | 8.265 M | 7.255 M | 5.219 M | 5.381 M | 3.010 M | |
| Selling general and admin | 4.095 M | 3.827 M | 3.790 M | 2.652 M | 3.136 M | 2.972 M | 3.217 M | 1.157 M | |
| Research and development | 8.593 M | 7.946 M | 7.199 M | 5.613 M | 4.119 M | 2.247 M | 2.164 M | 1.853 M | |
| Total expenses | 13.076 M | 12.132 M | 11.301 M | 8.923 M | 7.255 M | 5.219 M | 5.381 M | 3.010 M | |
| -7.22% | -6.85% | -21.04% | -18.69% | -28.06% | 3.10% | -44.06% | |||
| Operating income | -11.022 M | -10.051 M | -9.557 M | -6.254 M | -5.717 M | -3.404 M | -3.967 M | -5.824 M | |
| Ebit | -11.022 M | -10.051 M | -9.557 M | -6.254 M | -7.643 M | -3.700 M | -4.285 M | -2.786 M | |
| Pretax income | -11.987 M | -11.181 M | -3.015 M | -1.441 M | -7.643 M | -3.700 M | -4.285 M | -2.786 M | |
| -6.72% | -73.03% | -52.21% | 430.40% | -51.59% | 15.81% | -34.98% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -11.987 M | -11.181 M | -3.015 M | -1.441 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| 6.72% | 73.03% | 52.21% | 100.00% | ||||||
| Net income | -11.987 M | -11.181 M | -3.015 M | -1.441 M | -7.643 M | -3.700 M | -4.285 M | 7.304 M | |
| 6.72% | 73.03% | 52.21% | -430.40% | 51.59% | -15.81% | 270.46% |
